SeaSpine Holdings Corporation Stock News

SARTORIUS (SARTF) delivered earnings and revenue surprises of 6.56% and 6.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disord

CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder

Provides for up to an additional $10 million of liquidity Provides for up to an additional $10 million of liquidity

Here's why we like SeaSpine, Recursion Pharmaceuticals, and Agenus.

Here's why we like SeaSpine, Recursion Pharmaceuticals, and Agenus.

Company’s second fully commercialized interbody system featuring the novel WaveForm 3D printed technology and that addresses an estimated $200 million cervical market opportunity Company’s second

Company’s first full commercial launch of novel 3D printed interbody product franchise that addresses estimated $500 million market opportunity Company’s first full commercial launch of novel 3D p

Here's why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.

Here's why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.

SeaSpine Holdings Corporation (NASDAQ:SPNE ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Leigh Salvo – Investor Relations Keith Valentine – Chief Executive Officer

SeaSpine (SPNE) delivered earnings and revenue surprises of -28.57% and 3.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde

CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.